1. Executive Summary
2. Global Anti fungal Drugs Market Introduction
2.1. Global Anti fungal Drugs Market – Taxonomy
2.2. Global Anti fungal Drugs Market –Definitions
2.2.1. Drug Class
2.2.2. Route of Administration
2.2.3. Therapeutic Indications
2.2.4. Distribution Channel
3. Global Anti fungal Drugs Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Anti fungal Drugs Market Dynamic Factors - Impact Analysis
3.6. Global Anti fungal Drugs Market – Competition Landscape
3.7. Epidemiology
4. Global Anti fungal Drugs Market Analysis,2013 - 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market OpportunityAnalysis
5. Global Anti fungal Drugs Market, By Drug Class, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
5.1. Azoles
5.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Polyenes
5.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Echinocandins
5.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Allylamines
5.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Anti fungal Drugs Market Forecast, By Route of Administration, 2013 - 2017 and Forecast, 2017 – 2024
6.1. Oral
6.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Parenteral
6.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Topical
6.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Anti fungal Drugs Market Forecast, By Therapeutic Indications, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
7.1. Aspergillosis
7.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Candidiasis
7.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Dermatophytosis
7.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Anti fungal Drugs Market Forecast, By Distribution Channel, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
8.1. Retail pharmacies
8.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospital pharmacies
8.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Drug stores
8.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Online pharmacies
8.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
Market Opportunity Analysis
9. Global Anti fungal Drugs Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Anti fungal Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Therapeutic Indications, By Distribution Channel, and Region, 2018 – 2024
10. North America Anti fungal Drugs MarketAnalysis,2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
10.1. Drug ClassAnalysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Azoles
10.1.2. Polyenes
10.1.3. Echinocandins
10.1.4. Allylamines
10.1.5. Others
10.2. Route of Administration Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Oral
10.2.2. Parenteral
10.2.3. Topical
10.3. Therapeutic Indications Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Aspergillosis
10.3.2. Candidiasis
10.3.3. Dermatophytosis
10.3.4. Others
10.4. Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Retail pharmacies
10.4.2. Hospital pharmacies
10.4.3. Drug stores
10.4.4. Online pharmacies
10.5. Country Analysis 2016 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Anti fungal Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Therapeutic Indications, By Distribution Channel, and Region, 2018 – 2024
10.7. North America Anti fungal Drugs Market Dynamics – Trends
11. Europe Anti fungal Drugs Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
11.1. Drug Class Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Azoles
11.1.2. Polyenes
11.1.3. Echinocandins
11.1.4. Allylamines
11.1.5. Others
11.2. Route of Administration Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Oral
11.2.2. Parenteral
11.2.3. Topical
11.3. Therapeutic Indications Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Aspergillosis
11.3.2. Candidiasis
11.3.3. Dermatophytosis
11.3.4. Others
11.4. Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Retail pharmacies
11.4.2. Hospital pharmacies
11.4.3. Drug stores
11.4.4. Online pharmacies
11.5. Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Anti fungal Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Therapeutic Indications, By Distribution Channel, and Region, 2018 – 2024
11.7. Europe Anti fungal Drugs Market Dynamics – Trends
12. Asia-Pacific Anti fungal Drugs Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
12.1. Drug Class Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Azoles
12.1.2. Polyenes
12.1.3. Echinocandins
12.1.4. Allylamines
12.1.5. Others
12.2. Route of Administration Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Oral
12.2.2. Parenteral
12.2.3. Topical
12.3. Therapeutic Indications Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Aspergillosis
12.3.2. Candidiasis
12.3.3. Dermatophytosis
12.3.4. Others
12.4. Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Retail pharmacies
12.4.2. Hospital pharmacies
12.4.3. Drug stores
12.4.4. Online pharmacies
12.5. Country Analysis2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Anti fungal Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Therapeutic Indications, By Distribution Channel, and Region, 2018 – 2024
12.7. Asia-Pacific Anti fungal Drugs Market Dynamics – Trends
13. Latin America Anti fungal Drugs Market Analysis, 2012 - 2012 - 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
13.1. Drug Class Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Azoles
13.1.2. Polyenes
13.1.3. Echinocandins
13.1.4. Allylamines
13.1.5. Others
13.2. Route of Administration Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Oral
13.2.2. Parenteral
13.2.3. Topical
13.3. Therapeutic Indications Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Aspergillosis
13.3.2. Candidiasis
13.3.3. Dermatophytosis
13.3.4. Others
13.4. Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Retail pharmacies
13.4.2. Hospital pharmacies
13.4.3. Drug stores
13.4.4. Online pharmacies
13.5. Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Anti fungal Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Therapeutic Indications, By Distribution Channel, and Region, 2018 – 2024
13.7. Latin America Anti fungal Drugs Market Dynamics – Trends
14. Middle East and Africa Anti fungal Drugs Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
14.1. Drug Class Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Azoles
14.1.2. Polyenes
14.1.3. Echinocandins
14.1.4. Allylamines
14.1.5. Others
14.2. Route of Administration Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Oral
14.2.2. Parenteral
14.2.3. Topical
14.3. Therapeutic Indications Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Aspergillosis
14.3.2. Candidiasis
14.3.3. Dermatophytosis
14.3.4. Others
14.4. Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Retail pharmacies
14.4.2. Hospital pharmacies
14.4.3. Drug stores
14.4.4. Online pharmacies
14.5. Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Anti fungal Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Therapeutic Indications, By Distribution Channel, and Region, 2018 – 2024
14.7. MEA Anti fungal Drugs Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Pfizer, Inc. (U.S.)
15.2.2. Novartis AG (Switzerland)
15.2.3. Sanofi (France)
15.2.4. Merck & Co., Inc. (U.S.)
15.2.5. Enzon Pharmaceuticals, Inc. (U.S.)
15.2.6. Bayer AG (Germany)
15.2.7. Astellas Pharma, Inc. (Japan)
15.2.8. GlaxoSmithKline plc. (U.K.)
15.2.9. Mylan N.V. (U.S.), Tecan Group (Switzerland)
15.2.10. AureoGen Biosciences Inc. (U.S.)
16. Research Methodology
17. Key Assumptions and Acronyms